Abstract:Abstract Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that controls cell proliferation and survival downstream of integrin-matrix receptors. However, under deprivation of anchorage, FAK translocates to the nucleus. The nucleolus, a non-membrane structure within the nucleus, is important in the control of ribosome biogenesis, regulates the sequestration of nuclear proteins, and increased nucleolar size is a marker of aggressive tumors. Nucleostemin, a nucleolar-localized protein, acts to modulate cell cycle progression and anchorage-independent cell growth. Although many drugs have low efficacy on tumor cells cultured in suspension, nanomolar small molecule FAK inhibitor (PF-271 or PND-1186) addition can prevent anchorage-independent growth of tumor cells as spheroids through mechanism(s) that remain unresolved. Here, we show that pharmacological FAK inhibitor (FAK-I) treatment or kinase-dead (KD) FAK re-expression analyses reduced breast cancer (MDA-MB-231 and 4T1-L) anchorage-independent cell growth with a G0/G1 cell cycle block. This was associated with a specific decrease in nucleostemin protein levels. As FAK-KD forms a complex with nucleostemin, and proteasome inhibitor treatment increased nucleostemin levels in FAK-KD cells, FAK-KD may function as a scaffold to facilitate nucleostemin degradation. In orthotopic breast cancer mouse tumor models, oral FAK-I administration or FAK-KD expression resulted in smaller tumors, decreased Ki67 positive cells, and lower levels of tumor-associated nucleostemin. Ongoing experiments are focused on understanding the molecular mechanisms of FAK nucleolar localization and the regulation of nucleostemin protein levels. Our results point to a novel function of FAK in nucleolar function, spheroid growth, and breast cancer progression. Supported by NIH CA102310 and Susan G. Komen for the Cure (KG111237). Citation Format: Isabelle Tancioni, Sean Uryu, Nichol L. G. Miller, Christine Lawson, Christine Jean, Xiao Lei Chen, David D. Schlaepfer. FAK inhibition targets nucleostemin, a nucleolar protein, impacting breast cancer spheroid growth and tumor progression. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3814. doi:10.1158/1538-7445.AM2014-3814

Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs

FAK expression regulation and therapeutic potential

The Effects of Focal Adhesion Kinase on the Motility, Proliferation and Apoptosis of Caco2 and SMMC-7721 Cells

Focal Adhesion Kinase Expression: A Potential Tumor Therapy Target

The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells

Focal adhesion kinase: from biological functions to therapeutic strategies

Chapter 3 FAK Expression

The direct effect of Focal Adhesion Kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis

[The Role of FAK Expression Inhibition by RNA Interference on Liver Cancer Cells].

Functional and clinical characteristics of focal adhesion kinases in cancer progression.

Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis

Signal transduction by focal adhesion kinase in cancer

Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy

FAK downregulation suppresses stem-like properties and migration of human colorectal cancer cells

Development of Novel Focal Adhesion Kinase (FAK) Inhibitors for Targeting Cancer: Structural Insights and Therapeutic Potential

Inhibition of cell migration by focal adhesion kinase: Time-dependent difference in integrin-induced signaling between endothelial and hepatoblastoma cells

Abstract B39: Inhibiting Endothelial FAK Activity Blocks Tumor Cell Extravasation

[Effects of FAK expression level on proliferation and motility of colorectal carcinoma cells].

Abstract 3814: FAK Inhibition Targets Nucleostemin, a Nucleolar Protein, Impacting Breast Cancer Spheroid Growth and Tumor Progression

Research and Development of Focal-Adhesion Kinase(FAK) and the Inhibitors

Suppression of Human MDA-MB-435S Tumor by U6 Promoter-Driven Short Hairpin RNAs Targeting Focal Adhesion Kinase